share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mahatme Sandesh

SEC ·  May 31 16:20
Summary by Moomoo AI
In a recent transaction, Sandesh Mahatme, associated with CRISPR Therapeutics AG (CRSP), executed a stock transaction on May 30, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the post-transaction holdings were not disclosed in the announcement. Investors are advised to note the date of the transaction for any potential impact on the stock's performance.
In a recent transaction, Sandesh Mahatme, associated with CRISPR Therapeutics AG (CRSP), executed a stock transaction on May 30, 2024. The specific details regarding the number of shares involved, the nature of the shares, the transaction price, and the post-transaction holdings were not disclosed in the announcement. Investors are advised to note the date of the transaction for any potential impact on the stock's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more